Vasoconstrictor response to prostacyclin in rabbit pulmonary circulation

Area of Science:

• Pulmonary Physiology
• Vascular Pharmacology

Background:

• Prostacyclin (PGI2) is a potent vasodilator and inhibitor of platelet aggregation.
• Its effects on pulmonary vascular resistance, particularly in relation to age, are not fully understood.

Purpose of the Study:

• To investigate the age-dependent effects of prostacyclin (PGI2) on segmental vascular resistance in isolated rabbit lungs.
• To explore the role of cyclooxygenase products in mediating PGI2-induced vascular responses.

Main Methods:

• Isolated and blood-perfused rabbit lungs from adult, juvenile, and neonatal groups were used.
• Pulmonary artery pressure was measured, and subpleural arterioles/venules were analyzed using micropipette techniques.
• Indomethacin pretreatment was employed to block cyclooxygenase activity.

Main Results:

• PGI2 significantly increased total vascular resistance in adult rabbit lungs at doses of 10 micrograms/kg, but not in juvenile or neonatal lungs.
• Vasoconstriction in adult lungs primarily affected arteries.
• Indomethacin pretreatment abolished the vasoconstrictor response to PGI2.

Conclusions:

• PGI2-induced vasoconstriction in isolated rabbit lungs is both age- and dose-dependent.
• Cyclooxygenase products, potentially thromboxane A2, appear to mediate this vasoconstriction.